January 17, 2017
In China, North Korea, Trump admin drawing a dangerous 'red line'
In weeks that have been saturated by a presidential farewell address, cabinet confirmation hearings, a press conference from the presidential-elect, and new revelations of possible scandal, there has been little time or bandwidth to analyze the new administration’s perspective on international affairs.
But amidst the media bonanza, a glaring flaw in the Trump foreign policy approach has begun to emerge. One statement by the president-elect and another by the secretary of State nominee suggest that the Trump administration may soon find itself in a serious credibility quandary in Asia.
On North Korea and the South China Sea — two of Asia’s most pressing security hotspots — the Trump leadership has begun to make promises that could be disastrous to keep, but also costly to abandon.
Read the full article at The Hill.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
